(Q44074090)

29 November 2017

title

Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers (English)

1 reference

29 November 2017

1 reference

Ling Xue

1

1 reference

29 November 2017

Hua Zhang

2

1 reference

29 November 2017

Sheng Ma

3

1 reference

29 November 2017

Jian-Zhong Rui

4

1 reference

29 November 2017

Li-Yan Miao

5

1 reference

29 November 2017

publication date

10 November 2011

1 reference

29 November 2017

1 reference

29 November 2017

volume

88

1 reference

29 November 2017

issue

5-6

1 reference

29 November 2017

page(s)

288-294

1 reference

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

29 November 2017

cites work

1 reference

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation

21 January 2018

1 reference

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation

21 January 2018

1 reference

Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

21 January 2018

1 reference

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool.

21 January 2018

1 reference

A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma.

21 January 2018

1 reference

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects

21 January 2018

1 reference

A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.

21 January 2018

1 reference

Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients

21 January 2018

1 reference

Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

21 January 2018

1 reference

Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin

21 January 2018

1 reference

Extensions to the visual predictive check to facilitate model performance evaluation

21 January 2018

1 reference

Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients

21 January 2018

1 reference

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients

21 January 2018

1 reference

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

21 January 2018

1 reference

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients

21 January 2018

1 reference

Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000331856

1 reference

29 November 2017

1 reference